BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11776852)

  • 21. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
    Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
    Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.
    Fujimoto Y; Hampton LL; Luo LD; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1992 Feb; 52(4):1044-6. PubMed ID: 1310637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between mutation of tumor suppressor gene p53 and development of hepatocellular carcinoma].
    Zhu MH
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):245-7. PubMed ID: 7909744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
    Wang XH; Wang PL
    Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
    Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
    World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.
    Qian GS; Kuang SY; He X; Groopman JD; Jackson PE
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1126-9. PubMed ID: 12376521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The expression and localization of wild-type p53-GFP fused gene on human high-metastasis hepatocellular carcinoma cell line].
    He P; Tang Z; Ye S
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):105-7. PubMed ID: 10861118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Co-inactivation of the p53 and RB genes in human hepato cellular carcinoma].
    Murakami Y
    Nihon Rinsho; 1993 Feb; 51(2):375-9. PubMed ID: 8096551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 and hepatocellular carcinoma.
    Puisieux A; Ozturk M
    Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alteration of p53 gene during tree shrews' hepatocarcinogenesis].
    Su JJ; Li Y; Ban KC; Qin LL; Wang HY; Yang C; Ou C; Duan XX; Li YY; Yan RQ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):159-61. PubMed ID: 12681064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China.
    Long XD; Ma Y; Huang HD; Yao JG; Qu DY; Lu YL
    Mol Carcinog; 2008 Apr; 47(4):295-300. PubMed ID: 17849423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 gene in hepatocellular carcinomas from Australia.
    Vesey DA; Hayward NK; Cooksley WG
    Cancer Detect Prev; 1994; 18(2):123-30. PubMed ID: 8025894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of cell origin of human hepatocellular carcinoma according to p53 gene mutation].
    He B; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):335-8. PubMed ID: 9387269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.